The nation of Zimbabwe has declined a substantial US healthcare agreement valued at $367m (272 million pounds) over five years over Washington's insistence on confidential biological samples.
This move became public after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson later explained that the United States was seeking biological samples for research and profit while refused to share the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued dialogue to reach a deal agreeable to all parties so the nation's critical HIV programme can proceed.
Wider Context
Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to enhance openness and responsibility.
Based on reports, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for medical research without any certainty that the end products would be available to our citizens should a new pandemic emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining systems already established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This mechanism is intended to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but suggested that negotiations should continue since a large portion of the country's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
The situation underscores the continuing challenges between receiving crucial international aid and protecting a country's data in an ever more interconnected world.